Altre lingue Ondine Biomedical Inc.

Azioni

Mercato chiuso - London S.E. Altri mercati azionari 17:35:09 19/04/2024			Variaz. 5gg	Var. 1 gen.
6,75 ^GBX	0,00%		-10,00%	-22,86%

15/04	Steriwave di Ondine Biomedical riduce le SSI del 32%, come dimostra lo studio	AN
10/04	Le azioni di Ondine Biomedical balzano grazie all'approvazione di Steriwave da parte di HCA Healthcare	AN

Ondine Biomedical's Steriwave reduces SSI's by 32%, study shows	15/04
Ondine Biomedical shares jump as Steriwave approved by HCA Healthcare	10/04
HCA Healthcare UK Approves the Steriwave Light-Activated Antimicrobial Developed by Ondine Biomedical Inc	10/04
Ondine says introduction of Steriwave in ICU market could boost sales	04/04
Ondine Biomedical Inc. Prepares to Enter the Intensive Care Unit Market	04/04
Ondine Biomedical's Finance Chief Resigns; Interim CFO Named	28/03
Ondine Biomedical appoints new interim chief financial officer	28/03
Ondine Biomedical Inc. Announces Executive Appointments	28/03
Ondine Biomedical Inc. Announces Chief Financial Officer Changes	28/03
Ondine Biomedical achieves milestone with NHS trust's adoption of Steriwave	27/03
Ondine Biomedical Inc. - First commercial adoption of Steriwave by the NHS	26/03
Peel Hunt's RetailBook raises GBP2.5 million	25/03
Ondine Biomedical Wins First NHS Commercial Deal for Steriwave Treatment	25/03
Ondine Biomedical Inc. Announces Steriwave Study Shows 77% Drop in Antibody Use	21/03
Ondine Biomedical says commercial progress ahead of forecast	15/03
Ondine Biomedical Inc. Announces Steriwave Deploying in Eight New Sites	15/03
Cindrigo seeks Croatian exploration licence extension	08/03
Ondine Biomedical Inc. Starts First UK Health Economics Study	05/03
Ondine Biomedical touts efficacy of Steriwave post presenting research	31/01
Ondine Biomedical - Appointment of new Chief Financial Officer	17/01

Non ci sono risultati per questa ricerca